IRCT20210519051345N59招募中Unknown
Fasted-state in vivo bioequivalence study of Rivaroxaban 20 mg tablet manufactured by Ronak Co. compared with innovator product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
In vivo Bioequivalence study of Rosuvastatin tabletIRCT20220211053992N33Tabriz University of Medical Sciences24
招募中
不适用
Investigating In vivo Bioequivalence of Rosuvastatin TabletIRCT20210519051345N11Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Evererolimus tabletsIRCT20220211053992N31Tabriz University of Medical Sciences24
招募中
Unknown
Investigating bioequivalence of Voriconazole tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N30Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Primidone suspensioIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N17Tabriz University of Medical Sciences24